Plasma metabolic biomarkers for syndrome of phlegm and blood stasis in hyperlipidemia and atherosclerosis

Journal of Traditional Chinese Medicine

Volumn 32, Issue 4, 2012, Pages 578-583

  Bai, Dong ^a   Song, Jiannan ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Atherosclerosis; Biological markers; Hyperlipidemias; Metabolism; Phlegm and blood stasis

Indexed keywords

GLUCURONIC ACID; GLYCEROL; ISOLEUCINE; PALMITIC ACID; BIOLOGICAL MARKER;

ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; HEMOSTASIS; HUMAN; HYPERLIPIDEMIA; MASS FRAGMENTOGRAPHY; METABOLOME; PATTERN RECOGNITION; PROGNOSIS; RESPIRATORY TRACT DISEASE; SYNDROME OF PHLEGM; URINALYSIS; BLOOD; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; FEMALE; MALE; METABOLISM; PLASMA; SPUTUM;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYPERLIPIDEMIAS; MALE; PLASMA; SPUTUM;

MLCS; MLOWN;

EID: 84875801594     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(13)60074-6     Document Type: Article

References (22)

1. Song K, Li X. Progress and Perspective in application of Pattern Recognition for Metabolomics/Metabonomics. Sheng Wu Xin Xi Xue 2008; 6(2): 90-93.
2. Jia W, Liu P, Jiang J, et al. Application of metabonomics in complicated theory system research of traditional Chinese medicine. Zhong Guo Zhong Yao Za Zhi 2006; 31(8): 621-624.
3. Fang Q, Wang Z L, Ning T H, et al. Prevention advice of dyslipidemia. Zhong Hua Xin Xue Guan Za Zhi 1997; 25(3): 169-175.
4. Hirsch A T, Haskal Z J, Hertzer N R, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113(11): e463-654.
5. He S Q. Modern Chinese internal medicine. Beijing: China Medical Science Press, 1992: 602-603.
6. National Standards of Peoples Republic of China: Terminology of traditional Chinese medicine clinical diagnosis and treatment. GB/T16751.2-1997.
7. Zhang B S. Chinese internal medicine. Shanghai: Shanghai Science and Technology Press, 1985: 87-88.
8. Zheng X Y. Chinese traditional medicine new drug clinical research guiding principle. Beijing: China Medical Science Press, 2002: 85-86.
9. Shen Z Y, Wang W J. The reference standard of deficiency syndrome of Chinese medicine. Zhong Xi Yi Jie He Za Zhi 1986; 6(10):598-598.
10. Song J N, Liu D Y, Niu X H, Jin H, Li A H. The experimental study of the relationship between hyperlipemia and syndrome of phlegm. Zhong Guo Zhong Yi Ji Chu Yi Xue Za Zhi 1995;1(1):49-51.
11. Chen K J, Ma X C. The modern classification of traditional blood syndrome. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2000; 20(7): 487-488.
12. Song J N, Zhou X Q, Zhou Y P, Wang Y H, Lv A P. Discussing the theory of phlegm and stasis and the mechanism of Removing Both Phlegm and Blood Stasis. Yi Xue Yan Jiu Tong Xun 2001; 30(8): 24-25.
13. Song J N. Discussing the concept of phlegm and the relationship between phlegm and stasis from the angle of biochemistry. Zhong Guo Zhong Yi Ji Chu Yi Xue Za Zhi 2000; 6(3): 40-43.
14. Liu J L, Song J N, Lei L Y, et al. Differential Plasma Protein Profiles in Patients with Hyperlipidemia and Atherosclerosis of Different Patterns of Phlegmstasis Syndrome. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2010; 30(5): 482-487.
15. Bai D, Song J N. Study of Metabolic Biomarkersin Plasma of Patients with Dyslipidemia Based on Gas Chromatography-Mass Spectrometry and Graphical Models. Fen Xi Hua Xue 2012; 40(10): 1482-1487.
16. Sun Y N, Feng W, Liu Z. Essential empirical study of the deficiency of kidneyYin in diabetes mellitus rats based on metabonomics. Shang Dong Zhong Yi Yao Da Xue Xue Bao 2010; 34(1): 80-81.
17. Skeie B, Kvetan V, Gil K M, Rothkopf M M, Newsholme E A, Askanazi J. Branch-chain amino acids: their metabolism and clinical utility. Crit Care Med 1990; 18(5): 549-571.
18. Yu K, Sheng, G, Sheng J, et al. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J Proteome Res 2007; 6(7): 2413-2419.
19. Feng B, Wu S, Lv S, et al. Metabolic profiling analysis of a D galactosamine/lipopolysaccharide induced mouse model of fulminant hepatic failure. J Proteome Res 2007; 6(6): 2161-2167.
20. Zhang H S, Jia Y H, Hua H Y, et al. Metabonomics characteristics of angina pectoris induced by coronary artery disease with phlegmturbidity syndrome and bloodstasis syndrome. Xin Zhong Yi 2010; 42(6):12-15.
21. Yao G C, Chen C W. Drug-induced & toxic liver disease. Shanghai: Shanghai Scientific and Technical Publishers, 2002: 75-81.
22. Tang J H, Ye X Y, Liu J, Li P, Zhang Q, Hu J J. Effects of total flavonoids in Gingko Biloba on glucose and lipid metabolism and liver function in rats with insulin resistance. Shanghai Jiao Tong Da Xue Xue Bao (Yi Xue Ban) 2009; 29(2):150-153.